Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

Healthcare Medical Instruments & Supplies
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

InspireMD to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

PR Newswire September 1, 2015

InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2015

PR Newswire August 5, 2015

InspireMD Announces Distribution Partnership of its CGuard(TM) Embolic Prevention System with Penumbra, Inc.

PR Newswire August 5, 2015

InspireMD to Report Financial Results for the Second Quarter Ended June 30, 2015 on Wednesday, August 5th

PR Newswire July 14, 2015

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

PR Newswire July 7, 2015

InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference

PR Newswire May 22, 2015

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet(TM) Technology at EuroPCR 2015 Conference

PR Newswire May 12, 2015

InspireMD Reports Financial Results for the First Quarter Ended March 31, 2015

PR Newswire May 11, 2015

InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th

PR Newswire May 5, 2015

InspireMD Announces MGuard(TM) Prime Approval in Brazil

PR Newswire April 27, 2015

InspireMD Announces Completion of Sales Restructuring Program

PR Newswire April 15, 2015

InspireMD Plan of Compliance Accepted by NYSE MKT

PR Newswire March 16, 2015

InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

PR Newswire March 12, 2015

InspireMD Announces Closing of Public Offering for Approximately $13.7 Million

PR Newswire March 9, 2015

InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th

PR Newswire March 6, 2015

InspireMD Announces Public Offering for Approximately $13.5 Million

PR Newswire March 4, 2015

InspireMD Announces Proposed Public Offering of Common Stock and Warrants

PR Newswire March 3, 2015

InspireMD to Present at the Cowen and Company 35th Annual Healthcare Conference

PR Newswire February 26, 2015

InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015

PR Newswire January 27, 2015

InspireMD Announces Notification of NYSE MKT Listing Deficiency

PR Newswire January 21, 2015